Urolithiasis in HIV-Positive Patients Treated with Atazanavir
Clinical Infectious Diseases2007Vol. 45(8), pp. e105–e108
Citations Over TimeTop 10% of 2007 papers
C. Couzigou, Michel Daudon, J.‐L. Meynard, F Lebas, D. Higueret, L. Escaut, David Zucman, Jean Yves Liotier, J.-L. Quencez, K. Asselah, T. May, D. Neau, Daniel Vittecoq
Abstract
Among protease inhibitors, atazanavir has not been associated with urolithiasis in clinical studies. We describe 11 cases of atazanavir-associated urolithiasis in patients with human immunodeficiency virus (HIV) infection. Patients with low water intake, high urinary pH, and a prior history of urinary stones may have a higher risk of atazanavir-associated urine crystallization.
Related Papers
- → Quantitative Urine Culture in Patients with Urinary Tract Infection and Bacteremia(1986)33 cited
- → Pre-operative Urinary Tract Infection Increases Post-Operative Morbidity in Spine Patients(2020)2 cited
- → Bladder content and residual urine in renal transplant patients: measurement using ultrasonography and relevance to urinary tract infection(1986)
- CLINICAL VALUE OF LIMULUS TEST OF URINE IN THE DIAGNOSIS OF URINARY TRACT INFECTION(1984)
- → Estimation of IL-6 and IL-8 in the Urine and Serum of Children with Urinary Tract Infection(2021)